FDA Inspection 1172424 — ReFlow Medical
The FDA completed an inspection of ReFlow Medical on Jun 9, 2022 in San Clemente, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 9, 2022
- Fiscal Year
- 2022
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- San Clemente, CA (United States)